MOGAT1 gene is involved in the glycerolipid metabolism (ko00561), and codes the MGAT (monoacylglycerol acyltransferases) enzyme, which is active in human liver and its activity can represent a viable target for pharmacologic intervention to treat nonalcoholic fatty liver disease [38]. This evidence concerns the gene MGAT1 and metabolic dysfunction-associated steatotic liver disease.